Resultados de la búsqueda 221-230 of 9763 for Enzyme

  1. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    The postnatal diagnosis of Long QT Syndrome (LQTS) is suggested by a prolonged QT interval on 12 lead electrocardiogram (ECG),a positive family history ...

  2. La salud de adolescentes y preadolescentes Noticias de la Mayo Clinic

    News · enero 2025 · noviembre 2024 · octubre 2024 · septiembre 2024 · agosto 2024 · julio 2024 · junio 2024 · mayo 2024.

  3. Transplant Center de Mayo Clinic - Ensayos clínicos

    African Americans, Afro-Caribbeans, Hispanic Blacks, and Africans are more likely to have the APOL1 gene variants that cause kidney disease. APOLLO will test ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this registry is to collect and maintain samples of breast tissue from women and men undergoing surgery for a breast related concern at Mayo ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...

  8. Zenker's diverticulum

    The test most often done to diagnose Zenker's diverticulum is a barium swallow. In this test, a specialist takes a series of X-rays of the digestive tract after ...

  9. Neurocirugía - Ensayos clínicos - Mayo Clinic

    Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...